Ralf Kuriyel sold $681k of RGEN
Senior VP, R&D at REPLIGEN CORP. 3,517 shares at an average of $193.73, traded Mar 11, 2024, filed Mar 12, 2024.
Score components
- +15RoleOfficer
- +21Trade size$681k at market
- +5Share of holdings soldSold 13% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-030331, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 11, 2024 | MOption exercise Common Stock | +1,271 | $86.10 | $109k | 27,777 | Mar 12, 2024 |
| Mar 11, 2024 | SOpen-market sale Common Stock | -3,517 | $193.73 | $681k | 24,260 | Mar 12, 2024 |
| Mar 11, 2024 | MOption exercise Stock Option (Right to Buy)derivative | +1,271 | $0.00 | $0 | 0 | Mar 12, 2024 |
Related signals
Other insiders at REPLIGEN CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $1.0M 5,535 shares | -12% | |
| 20Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $2.5M 12,946 shares | -23% | |
| 20Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $977k 5,426 shares | -10% | |
| 23Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $504k 3,035 shares | -6% | |
| 15Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $977k 5,426 shares | -9% | |
| 11Weak | REPLIGEN CORP | Jason K Garland CFO | $80k 530 shares | -3% | |
| 12Weak | REPLIGEN CORP | Jason K Garland CFO | $106k 733 shares | -4% | |
| 24Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $536k 3,832 shares | -7% | |
| 21Weak | RGENsell REPLIGEN CORP | Karen A Dawes director | $44k 275 shares | -0% | |
| 50Moderate | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $1.2M 7,041 shares | -16% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.